High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
about
Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiformeQuantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesThe role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosisModern brain tumor imagingClinical decision support systems for brain tumor characterization using advanced magnetic resonance imaging techniquesOutcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.Perfusion MRI: the five most frequently asked clinical questions.AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.Advanced magnetic resonance imaging biomarkers of cerebral metastases.Intracranial metastases: spectrum of MR imaging findings.Lesions masquerading as acute stroke.Advanced MRI in malignant neoplasms of the uterus.3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.Imaging of brain metastasesIntracranial Masses with Perilesional Edema: Differential Diagnosis with Perfusion CT.ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.Fast spectroscopic multiple analysis (FASMA) for brain tumor classification: a clinical decision support system utilizing multi-parametric 3T MR data.Imaging biomarkers in primary brain tumours.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.Morphometric model for discrimination between glioblastoma multiforme and solitary metastasis using three-dimensional shape analysis.Perfusion MR imaging and proton MR spectroscopic imaging in differentiating necrotizing cerebritis from glioblastoma multiforme.Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patientsMultiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy.Current approaches to the treatment of metastatic brain tumours.Multimodality intraoperative MRI for brain tumor surgery.Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma.Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerNeuroradiological viewpoint on the diagnostics of space-occupying brain lesions.Cerebellar glioblastoma multiforme presenting as hypertensive cerebellar hemorrhage: case reportClinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.In vivo characterization of several rodent glioma models by 1H MRSMR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma.Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.
P2860
Q21135142-4CF3A8F7-B540-4279-936D-22576226B68DQ26743358-A4864796-212E-450B-92A6-0B1F4E24FEC4Q26825055-55441E89-4D4A-44E3-B0FC-6A3C93F8EB1DQ27002344-F8359B9B-E739-42A8-B837-6ECAC7F94912Q27010896-76415B80-80A7-4C30-B389-3B82AE2CC7B9Q30405581-F8DF10FA-6735-4582-B648-087B382A891FQ30416198-298C9FFA-622F-45A7-80CD-6EE0F6E2B67CQ30490422-952147EC-85D9-4174-A0D4-4A7E44375C79Q30493217-0E744D37-27C3-47AD-A022-C962B25816E1Q30560150-23F6A9CD-994F-44EC-97E7-512F0BFC301CQ30574051-3B1CCD18-A0D7-4919-82A0-00EF0ED0421DQ30582481-ADCB0EFC-1CA0-4524-894B-1EBDD05553CDQ30586370-A60BEAAF-B873-45D6-B693-D93AF33C9DEEQ30587309-8C86D2B1-01AE-4490-8FF8-B8D46CDD2F1AQ30635460-4A9F1569-3848-4F38-96DB-134F0713EAE7Q30669308-EFDEE523-F491-40EC-9CA5-50A955F13ADEQ30833655-C71B0475-97FC-4043-82E8-E4678D30AD8CQ30836527-8F62C994-2A47-4AC8-A498-A9716D108C43Q30880129-CFFC856E-A122-4C73-A871-3E2AC7E0707AQ30938805-2FDFE52D-181B-46D1-AF36-8BEFFF0D8C91Q30976984-A0D5F218-E0FB-48B4-A6BB-8F2A0BEF9927Q30980326-E3B41CAC-DD56-4DBE-924C-C3024B69AA46Q31097459-71AE6E95-6143-432A-8594-DCD492200A2CQ31143153-78C4BBAC-6340-41A0-8D83-4B2772E2F035Q31146015-E4C8F1C2-9D34-4B60-8442-D1510A96A4B4Q33556108-D12C2910-D904-4788-9C8F-CBEA266B58CEQ33696559-49DA1C04-6E87-4124-9AB5-56011EC33F4EQ33718297-64AFBDA1-1BF7-4FFB-998F-A90917577CEFQ33793833-53A02942-A005-4A23-B8F9-881A9192ECE9Q33862844-C6A1BF68-E720-4BF9-BA25-322273CA22A4Q33881902-F72FABB7-3D40-4FF6-8F12-20317B061E98Q33888131-CD00D170-47F8-4DAC-BAAB-38F2F826A074Q33946502-FEFA43EE-CC84-42D9-B0B4-88E0494F6F9BQ34011150-EB1F824A-3034-4A79-9C41-2C2A87A42FDEQ34033507-D9247EBA-BE9D-47C9-9DBF-5A255012A81BQ34053148-B78A9839-CEAA-4F89-9827-3628D38D1CD0Q34077408-6934ED2E-4A90-4144-8671-69888BCEA5CBQ34203930-6BA80B2A-593B-4624-9CC8-A5E211B38255Q34320779-6E55E10F-4CDF-40E4-8372-7DE3478B11EBQ34389144-BEB2C65B-A4FA-4E0E-BAE7-FC83F43F00C0
P2860
High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@en
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@nl
type
label
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@en
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@nl
prefLabel
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@en
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@nl
P2093
P1433
P1476
High-grade gliomas and solitar ...... oton spectroscopic MR imaging.
@en
P2093
Andrew W Litt
Edmond A Knopp
John Arnett
Soonmee Cha
P304
P356
10.1148/RADIOL.2223010558
P407
P50
P577
2002-03-01T00:00:00Z